156 related articles for article (PubMed ID: 15200057)
1. Beta-tricalcium phosphate combined with recombinant human bone morphogenetic protein-2: a substitute for autograft, used for packing interbody fusion cages in the canine lumbar spine.
Ohyama T; Kubo Y; Iwata H; Taki W
Neurol Med Chir (Tokyo); 2004 May; 44(5):234-40; discussion 241. PubMed ID: 15200057
[TBL] [Abstract][Full Text] [Related]
2. Beta-tricalcium phosphate as a substitute for autograft in interbody fusion cages in the canine lumbar spine.
Ohyama T; Kubo Y; Iwata H; Taki W
J Neurosurg; 2002 Oct; 97(3 Suppl):350-4. PubMed ID: 12408391
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
Boden SD; Kang J; Sandhu H; Heller JG
Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
[TBL] [Abstract][Full Text] [Related]
4. Lumbar spinal fusion with β-TCP granules and variable Escherichia coli-derived rhBMP-2 dose.
Pelletier MH; Oliver RA; Christou C; Yu Y; Bertollo N; Irie H; Walsh WR
Spine J; 2014 Aug; 14(8):1758-68. PubMed ID: 24486479
[TBL] [Abstract][Full Text] [Related]
5. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Mummaneni PV; Pan J; Haid RW; Rodts GE
J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
[TBL] [Abstract][Full Text] [Related]
6. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Kai T; Shao-qing G; Geng-ting D
Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors.
Kandziora F; Bail H; Schmidmaier G; Schollmeier G; Scholz M; Knispel C; Hiller T; Pflugmacher R; Mittlmeier T; Raschke M; Haas NP
J Neurosurg; 2002 Jul; 97(1 Suppl):40-8. PubMed ID: 12120650
[TBL] [Abstract][Full Text] [Related]
9. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrow-derived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion.
Abbah SA; Lam CX; Ramruttun AK; Goh JC; Wong HK
Spine (Phila Pa 1976); 2011 Oct; 36(21):1752-9. PubMed ID: 21673630
[TBL] [Abstract][Full Text] [Related]
10. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.
Kaiser MG; Groff MW; Watters WC; Ghogawala Z; Mummaneni PV; Dailey AT; Choudhri TF; Eck JC; Sharan A; Wang JC; Dhall SS; Resnick DK
J Neurosurg Spine; 2014 Jul; 21(1):106-32. PubMed ID: 24980593
[TBL] [Abstract][Full Text] [Related]
11. Cervical interbody fusion cages. An animal model with and without bone morphogenetic protein.
Zdeblick TA; Ghanayem AJ; Rapoff AJ; Swain C; Bassett T; Cooke ME; Markel M
Spine (Phila Pa 1976); 1998 Apr; 23(7):758-65; discussion 766. PubMed ID: 9563105
[TBL] [Abstract][Full Text] [Related]
12. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2.
Burkus JK; Dorchak JD; Sanders DL
Spine (Phila Pa 1976); 2003 Feb; 28(4):372-7. PubMed ID: 12590213
[TBL] [Abstract][Full Text] [Related]
13. Osteoinductive activity of ErhBMP-2 after anterior cervical diskectomy and fusion with a ß-TCP interbody cage in a goat model.
Wang H; Zhang F; Lv F; Jiang J; Liu D; Xia X
Orthopedics; 2014 Feb; 37(2):e123-31. PubMed ID: 24679197
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.
Parker RM; Malham GM
Eur Spine J; 2017 Mar; 26(3):754-763. PubMed ID: 28028645
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bioabsorbable multiamino acid copolymer/α-tri-calcium phosphate interbody fusion cages in a goat model.
Chunguang Z; Yueming S; Chongqi T; Hong D; Fuxing P; Yonggang Y; Hong L
Spine (Phila Pa 1976); 2011 Dec; 36(25):E1615-22. PubMed ID: 21270683
[TBL] [Abstract][Full Text] [Related]
16. Anterior lumbar interbody fusion with carbon fiber cage loaded with bioceramics and platelet-rich plasma. An experimental study on pigs.
Li H; Zou X; Xue Q; Egund N; Lind M; Bünger C
Eur Spine J; 2004 Jul; 13(4):354-8. PubMed ID: 14730438
[TBL] [Abstract][Full Text] [Related]
17. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.
Dai LY; Jiang LS
Spine (Phila Pa 1976); 2008 May; 33(12):1299-304. PubMed ID: 18496340
[TBL] [Abstract][Full Text] [Related]
18. Instrumented anterior lumbar interbody fusion with equine bone protein extract.
Li H; Zou X; Springer M; Briest A; Lind M; Bünger C
Spine (Phila Pa 1976); 2007 Feb; 32(4):E126-9. PubMed ID: 17304121
[TBL] [Abstract][Full Text] [Related]
19. Comparison of BMP-2 and combined IGF-I/TGF-ss1 application in a sheep cervical spine fusion model.
Kandziora F; Pflugmacher R; Scholz M; Knispel C; Hiller T; Schollmeier G; Bail H; Schmidmaier G; Duda G; Raschke M; Haas NP
Eur Spine J; 2002 Oct; 11(5):482-93. PubMed ID: 12384758
[TBL] [Abstract][Full Text] [Related]
20. Fusion rate and clinical outcome in anterior lumbar interbody fusion with beta-tricalcium phosphate and bone marrow aspirate as a bone graft substitute. A prospective clinical study in fifty patients.
Lechner R; Putzer D; Liebensteiner M; Bach C; Thaler M
Int Orthop; 2017 Feb; 41(2):333-339. PubMed ID: 27770186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
